SkinHealth Systems (SKIN) Income from Continuing Operations (2020 - 2026)
SkinHealth Systems' (SKIN) quarterly Income from Continuing Operations came in at -$2.7 million in Q2 2026, down 113.54% year-over-year from $19.7 million in Q2 2025, and up 59.65% quarter-over-quarter from -$6.6 million in Q1 2026.
Analysis
SkinHealth Systems (SKIN) Income from Continuing Operations (2020 - 2026) Analysis & Trends
SkinHealth Systems (SKIN) has reported Income from Continuing Operations for 7 consecutive years, with -$2.7 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Income from Continuing Operations fell 113.54% year-over-year to -$2.7 million in Q2 2026; TTM through Jun 2026 was -$28.4 million, a 49.52% decrease from a year earlier, with the FY2025 full-year figure at -$9.5 million, up 67.29% from the prior year.
- Income from Continuing Operations was -$2.7 million for Q2 2026 at SkinHealth Systems, up from -$6.6 million in the prior quarter.
- Over five years, Income from Continuing Operations peaked at $31.5 million in Q1 2022 and troughed at -$73.8 million in Q3 2023.
- A 5-year average of -$5.8 million and a median of -$4.6 million in 2026 frame the typical range for Income from Continuing Operations.
- Across the five-year window, Income from Continuing Operations tumbled 91059.26% in 2023 and jumped 7819.28% in 2025, its largest moves.
- Over 5 years, Income from Continuing Operations stood at $6.6 million in 2022, then tumbled by 243.64% to -$9.4 million in 2023, then dropped by 9.58% to -$10.3 million in 2024, then increased by 21.69% to -$8.1 million in 2025, then surged by 67.0% to -$2.7 million in 2026.
- The last three Income from Continuing Operations figures came in at -$2.7 million (Q2 2026), -$6.6 million (Q1 2026), and -$8.1 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 1.48 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 1.28 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 905.00 Mn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 241.40 Mn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | -92.00 Mn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 249.10 Mn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 201.00 Mn |
| 10 | SkinHealth Systems | 89.77 Mn | -116.30 Mn | 49.34 Mn | -2.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.67 Mn |
| Mar 31, 2026 | -6.61 Mn |
| Dec 31, 2025 | -8.09 Mn |
| Sep 30, 2025 | -11.05 Mn |
| Jun 30, 2025 | 19.72 Mn |
| Mar 31, 2025 | -10.10 Mn |
| Dec 31, 2024 | -10.33 Mn |
| Sep 30, 2024 | -18.29 Mn |
| Jun 30, 2024 | 249,000.00 |
| Mar 31, 2024 | -638,000.00 |
| Dec 31, 2023 | -9.43 Mn |
| Sep 30, 2023 | -73.84 Mn |
| Jun 30, 2023 | 3.37 Mn |
| Mar 31, 2023 | -20.22 Mn |
| Dec 31, 2022 | 6.56 Mn |
| Sep 30, 2022 | -81,000.00 |
| Jun 30, 2022 | 6.29 Mn |
| Mar 31, 2022 | 31.46 Mn |
| Dec 31, 2021 | -20.97 Mn |
| Sep 30, 2021 | -215.15 Mn |